Reply to: Versatility of the clone-censor-weight approach: response to ''trial emulation in the presence of immortal-time bias''
Int J Epidemiol
.
2021 May 17;50(2):696.
doi: 10.1093/ije/dyaa225.
Authors
Camille Maringe
1
,
Sara Benitez Majano
1
,
Aimilia Exarchakou
1
,
Matthew Smith
1
,
Bernard Rachet
1
,
Aurélien Belot
1
,
Clémence Leyrat
1
2
Affiliations
1
Inequalities in Cancer Outcomes Network, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
2
Medical Statistics Department, London School of Hygiene & Tropical Medicine, London, UK.
PMID:
33524137
PMCID:
PMC8128474
DOI:
10.1093/ije/dyaa225
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Bias*
Clone Cells
Humans
Time Factors
Grants and funding
C7923/A18525/CRUK_/Cancer Research UK/United Kingdom
MR/S01442X/1/MRC_/Medical Research Council/United Kingdom
MR/M013278/1/MRC_/Medical Research Council/United Kingdom
18525/CRUK_/Cancer Research UK/United Kingdom
MR/T032448/1/MRC_/Medical Research Council/United Kingdom
29018/CRUK_/Cancer Research UK/United Kingdom